Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol versus placebo for ICU delirium
NL-OMON48650Phase 3Recruiting
- Sponsor
- Erasmus MC
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Haloperidol with Placebo (2 arms). Primary endpoint: Delirium- and coma-free days at ICU. Started Feb 2018; status: recruiting.
02
Drugs
haloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on NL-OMON48650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48650.